.
hr.) + aetiocholanolone (Mg./24 hr.)-which on appropriate substitution of found values gave rise to the " discriminant func- tion." The discriminant was frequently positive in subjects responsive to such ablative procedures and negative in subjects showing no response.
Later publications from the same group of workers suggested that the discriminant appeared to be of some prognostic value in early disease. A large proportion of patients with early disease were found to have negative discriminants, this being very uncommon in normal subjects (Bulbrook, Hayward, Spicer, and Thomas, 1962) . Furthermore, that group of patients with a positive discriminant at the time of mastectomy was found to have a lower recurrence rate and higher survival rate than the group with a negative discriminant (Bulbrook, Hayward, and Thomas, 1964) . These various developments have given rise to a continuing series of publications from the same centre, reviewed by Atkins (1966) . Recent publications in a similar context from other centres have been restricted to considerations of selection for endocrine ablation (Wilson, Crocker, Fairgrieve, Bartholomay, Emerson, and Moore, 1967; Juret, Hayem, and Flaisler, 1964;  Kumaoka, Abe, Sakauchi, Takatani, and Kusama, 1966) .
The foundation of such developments has been empirical.
The in vivo biosynthesis of dehydroepiandrosterone, A4-androsten-3,17-dione, and cortisol by the human adrenal gland has been studied in patients with advanced breast cancer in whom this organ was infused in situ with precursor A5-pregnenolone (tritiated) (Deshpande, Jenson, Bulbrook, and Doouss, 1967 ratio of (total) 1 1-DOOS to 17-OHCS for our subjects. At a later stage it was found practicable to estimate aetiocholanolone by a gas-chromatographic method, and the discriminant could then be calculated. We present data relating these two values, and comment on their application to our patients.
Work concurrently carried out at another centre by Miller, Durant, Jacobs, and Allison (1967) , using methods somewhat different from ours, introduced the ratio of 11-DOOS to 17-OHCS as an " alternative discriminant." In a study applied retrospectively to their own series of cases, Thomas, Bulbrook, and Hayward (1967) have shown such a ratio to give the same correlation with response to endocrine ablation as did their discriminant.
Methods
Urinary 17-OHCS were measured by a modification of the method of Few (1961) . For the final extraction ethylene dichloride was used. Results were expressed in terms of dehydroepiandrosterone. The methods used to measure the urinary excretions of total 11-DOOS and of aetiocholanolone were closely modelled on those of Bulbrook's laboratory (Thomas and Bulbrook, 1966) . All Zimmerman colorimetry differed from the practice in the latter in that organic base was used in place of potassium hydroxide (James and De Jong, 1961; Ahlquist, 1967) . We believe that the consequent differences in chromogenicity would lead to no more than a minor discrepancy. Towards the end of the clinical work a cross-check was made with Bulbrook's laboratory, the results showing a good measure of agreement (unpublished data). In brief, urine was successively subjected to solvent extraction, glucuronidase hydrolysis, solvolysis, and paper chromatography. Divided aliquots of eluted 11-DOOS were estimated by (a) the Zimmerman reaction (for total 11-DOOS) and (b) gas chromatography (for aetiocholanolone: proportionality calculation).
We have examined urine from 37 normal women, 63 cases of early breast cancer, and 107 cases of late breast cancer. The normal subjects were paramedical workers and their relatives and friends. Urine samples (24-hour) were taken either 10 days after mastectomy for patients having surgery in this hospital or immediately on admission here for postoperative radiotherapy, and always before x-ray artificial menopause. The late cases were initially sampled before hormone treatment or at least two weeks free of any such treatment. Observations on subsequent serial values are also presented in both early and late cases. Urine was collected without preservative, returned to the laboratory promptly, and an aliquot stored at -180 C. for brief periods, if necessary, before analysis. Stale urines were rejected.
Early cases are defined as those in which treatment was given with curative intent (stages 1, 2, or 3-Manchester staging). These cases were given such surgical treatment as was thought appropriate, with local radiotherapy and x-ray artificial menopause added according to Manchester principles (Paterson and Russell, 1959a (see Bulbrook, 1965) .
Results

Relation Between Ratio and Discrminant
The age distribution of the subjects is shown in Fig. 1 Miller et al. (1967) .
In Figs. 2 and 3 are shown related values of the ratio and the discriminant for urine samples from 37 normal women and from 72 patients with breast cancer (both early and late) in whom both investigations were carried' out. The regression lines are as indicated, the x intercepts (ratio) being 0.20 for the normal group and 0.15 for the cancer group. This difference in intercept could in part be determined by the age bias already commented on. It is seen that, with two exceptions only, the ratio was found to exceed 0.20 in the normal group; no negative' discriminants were found. In the cancer group ratio 
Early Cases
The ratio values found with the 63 early cases are plotted en Fig. 4 according to stage and in terms of the observed subsequent progress of the disease. Clinical assessment was made at periods ranging from six months to two and a half years after the urine analysis. In those cases in which recurrence or metastasis occurred the general pattern appears random, and no helpful guidance regarding individual prognosis has yet been observed. The recurrence pattern at 12 months has also been examined. In this preliminary analysis the mean ratio of patients whose disease has recurred or metastasized is similar to that of patients remaining well at 12 months. One patient (stage 1) with a persistently high ratio (initially 0.85) developed a possible second primary in the contralateral breast at nine months after the first radical mastectomy. She remained well after a further local mastectomy and has been classed in Fig. 4 as a well case.
Late Cases
Response to therapy has been assessed as follows: (1) unequivocal objective response-all known disease showing measurable regression; and (2) less marked objective response-regression but quantitatively less definite.
The duration of such response has ranged from 3 to 30 months, with a mean of 10 months, but some cases are still in remission. Subjective improvement alone, so common after prednisone and on occasion after androgens, has not been rated as response.
In Fig. 5 5-Breast CancerLate Cases.-In 34 late cases serial values of the ratio were recorded over periods extending from 1 to 27 months from the initial assay. In most cases the patient was off all hormones at the time of urine sampling for the later values but a few patients were taking stilboestrol. The levels showed considerably more variation than in the early cases. Several cases showed a fall in the ratio as the disease progressed. A fall in 11-DOOS accompanied by a rise in 17-OHCS, producing a decrease in the ratio, is known to be a general feature of terminal illness. However, instances were found where a low ratio was maintained in long-term survival. One patient showed a remarkable rise in ratio as her general condition improved after cyclophosphamide therapy. Values found in illustrative cases are shown in Fig. 6 . Initial hopes that response of individual patients to hormone therapy or x-ray artificial menopause would be associated with a consistent change in serial values did not materialize.
Discussion
The relation we have explored between the ratio and the discriminant reveals a pattern similar to that noted earlier by Miller et al. (1967) in introducing their " alternative discriminant" (11-DOOS/17-OHCS). However, only two cases in which aetiocholanolone was less than 30 % of the total 11-DOOS were encountered in our study.
The original application of the discriminant is reported to be of continuing value for the optimal selection of cases for ablative surgery (Bulbrook, 1965) . Earlier reports, however, indicating an appreciable proportion of negative discriminants in early breast cancer (Bulbrook et al., 1962 (Bulbrook et al., , 1964 and which prompted our interest, are not supported by the present study. Our own findings in the early group may be summarized: ratio 6i63<0.15 ; negative discriminant 1/12. They thus indicate a very small proportion of cases with a presumptively negative discriminant. It is, however, proper to observe that it is possible that our calculated discriminant may deviate slightly in certain cases from the value which would be found in Bulbrook's laboratory, for reasons made apparent in the Methods section.
It has been reported that " the amounts of steroids found in the urine (10 days after mastectomy) are not necessarily characteristic of the amounts found at other times in the course of the disease" (Bulbrook and Hayward, 1966 (1966) . In embarking on our study it was an initial stipulation that subjects should be " off all drugs." It became apparent that such a ,~~~~~,~~~~~I~~~B RITISH Alllquist et al.
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rule is generally impossible to maintain under practical circumstances. Several ill patients cannot be denied pain relief, nor is full control over self-medication practicable in outpatients. Even the ubiquitous anodyne aspirin may be a source of error ; it is well known that salicylate metabolites may compete for glucuronidase (Stempfel, Sidbury, and Migeon, 1960) . In the course of our investigations it became the practice to screen all urines with ferric chloride ; salicylatepositive urines were then processed with a double amount of glucuronidase. In about half a dozen instances, including two "normal" subjects, the methods employed gave indeterminate values. These cases have been excluded. It is entirely feasible that concealed errors may be quite common. It must be accepted that a proportion of results may be spurious, and it should be emphasized that individual results should be interpreted with caution.
It has been remarked that " it is unlikely that the discriminant will be of prognostic use in old patients" (Bulbrook et al., 1964) . In this hospital 460% of patients treated for breast cancer are> 60 years of age and 33 % are> 65. We have attempted to exclude patients over 65, and thus have been obliged to disqualify a large proportion of our patients from consideration.
The investigations reported in this article have led us to conclude that study of the ratio or of the discriminant has given us no useful prognostic indication for individual patients. We are not in a position to comment on the original application of the discriminant-that is, selection for endocrine ablative surgery-for reasons given earlier. In this (Bellanti et al., 1965) . The present paper reports the relative quantities of IgM and IgG H.I. antibodies in postnatal rubella infection, and describes a routine method for the diagnosis of rubella in which a single serum sample is used.
Materials and Methods
Treatment of Serum Samples.-Ordinarily 0.2 ml. of 1: 5 dilution of untreated serum was used in the sedimentation analysis. In a few cases 0.1 ml. of undiluted serum was used in an attempt to demonstrate slight amounts of IgM antibody. To test the effect of kaolin some sera were treated as described in the rubella H.I. method of Stewart et al. (1967) . To demonstrate sulphydryl reactivity treatment with 0.1 M 2-mercaptoethanol for two hours at 370 C. plus overnight dialysis against Dulbecco's phosphate buffered saline at 4°C. was given. Both treatments resulted in a 1: 5 dilution of the serum, and subsequently 0.2 ml. was analysed.
Sedimentation Analysis.-The samples were layered on top of linear 37-12.5% w/v sucrose gradients in phosphate-buffered saline (Vaerman et al., 1963) and centrifuged in a Spinco SW 39 rotor at 35,000 r.p.m. for 14j hours. Twelve to 14 fractions were collected dropwise through the bottom of the tubes. The linearity of the gradients was checked by means of an Abbe refractometer.
Titration.-The original rubella H.I. method was employed (Stewart et al., 1967) . The antigen was prepared in rubellainfected BHK 21/13 S suspension cultures (Vaheri et al., 1965) by treatment of the tissue culture fluid with Tween 80 and ether (Halonen et al., 1967) . The H.I. titres varied between 1:8 and 1: 64. The titrations were carried out on microtitre V-plates with the use of a multimicrodiluter handle.
Results
Development of Antibody Response Pattern.-Five rubella cases in schoolchildren aged 10 were followed by serum samples taken at intervals after the onset of infection. (The total H.I. titres ranged at one week from 1: 160 to I: 640, at three weeks from 1: 640 to 1: 2,560, and at six weeks from 1: 640 to 1: 2,560.) At one week (Fig. I A) a noticeable amount of IgM antibody was detected in all cases as well as IgG antibody. The relative quantity of IgG antibody was, however, always greater than that of IgM type. Three weeks after the rash the IgM antibody was still measurable in four out of five cases (Fig. 1  B) . The fifth sample can apparently be regarded as an example of a weak IgM response, since such early disappearance of IgM immune globulin has not been found in any other rubella case studied so far. Six weeks after the rash there was no detectable amount of 1gM in any serum (Fig. I C) . In several other rubella cases with significant rise (fourfold) in total H.I. titre IgM antibody was constantly demonstrated in a serum sample obtained one to two weeks after the rash. * University Department of Virology, and Virus Laboratory, Orion, Helsinki, Finland.
